Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Sci Rep ; 11(1): 8984, 2021 04 26.
Article in English | MEDLINE | ID: mdl-33903630

ABSTRACT

Despite the number of studies focused on sense-antisense transcription, the key question of whether such organization evolved as a regulator of gene expression or if this is only a byproduct of other regulatory processes has not been elucidated to date. In this study, protein-coding sense-antisense gene pairs were analyzed with a particular focus on pairs overlapping at their 5' ends. Analyses were performed in 73 human transcription start site libraries. The results of our studies showed that the overlap between genes is not a stable feature and depends on which TSSs are utilized in a given cell type. An analysis of gene expression did not confirm that overlap between genes causes downregulation of their expression. This observation contradicts earlier findings. In addition, we showed that the switch from one promoter to another, leading to genes overlap, may occur in response to changing environment of a cell or tissue. We also demonstrated that in transfected and cancerous cells genes overlap is observed more often in comparison with normal tissues. Moreover, utilization of overlapping promoters depends on particular state of a cell and, at least in some groups of genes, is not merely coincidental.


Subject(s)
Gene Expression Regulation, Neoplastic , Neoplasms/genetics , Promoter Regions, Genetic , Sequence Analysis, RNA , Transcription Initiation Site , Transcription, Genetic , Gene Library , Humans , Neoplasms/metabolism
2.
Sensors (Basel) ; 21(8)2021 Apr 20.
Article in English | MEDLINE | ID: mdl-33923949

ABSTRACT

Thermionic emission sources are key components of electron impact gas ion sources used in measuring instruments, such as mass spectrometers, ionization gauges, and apparatus for ionization cross-section measurements. The repeatability of the measurements taken with such instruments depends on the stability of the ion current, which is a function, among other things, of the electron beam current and electron accelerating voltage. In this paper, a laboratory thermionic electron beam current and accelerating voltage controller is presented, based on digital algorithm implementation. The average value of the percentage standard deviation of the emission current is 0.021%, and the maximum electron accelerating voltage change versus the emission current is smaller than 0.011% in the full operating range of the emission current. Its application as a trap current or emission current-regulated ion source power supply could be useful in many measuring instruments, such as in microelectromechanical system (MEMS) mass spectrometers as universal gas sensors, where a stable emission current and electron energy are needed.

3.
Rapid Commun Mass Spectrom ; 25(6): 689-92, 2011 Mar 30.
Article in English | MEDLINE | ID: mdl-21337629

ABSTRACT

The implementation of a non-linear combination of two reference voltages to control the anode voltage in the previously described biasing system of an electron source with a hot cathode allows elimination of the correlation between the emission current and the accelerating voltage. The presented system is highly suitable for applications in electron-impact mass spectrometers, ionization gauges and other instruments (for example, electron microscopes).

4.
Pol Arch Med Wewn ; 111(4): 467-75, 2004 Apr.
Article in Polish | MEDLINE | ID: mdl-15517761

ABSTRACT

AIM: To assess correlation between exercise tolerance and Doppler-derived indices of right ventricular (RV)--pulmonary arterial coupling in patients with different location of vascular lesions causing pulmonary hypertension (PH). MATERIAL: 45 patients: 21 with thromboembolic (TE-PH) and 24 with arterial PH defined as systolic pulmonary arterial pressure (SPAP) > 40 mm Hg. The two groups were similar as far as SPAP (74,8 +/- 15,2 vs 76.5 +/- 14,1 mm Hg, p = ns) and distance covered during 6 minute walk test (339 +/- 116 vs 320 +/- 127, p = ns) are concerned. RESULTS: Flow velocity curve in the RV outflow tract were different in the two groups. Time from onset to peak velocity of ejection (acceleration time, AcT) as well as to midsystolic deceleration were shorter in TE-PH then in arterial PH (59.0 +/- 6.3 vs 68.1 +/- 15.4 msec, p = 0.015 and 123.8 +/- 17.9 vs 137.9 +/- 29.7 msec, p = 0.071, respectively). In the whole studied group as well as in arterial PH significant correlation between exercise tolerance and Doppler-derived indices of RV--pulmonary arterial coupling were found (r = 0.51, p < 0.001 and r = 0.72, p = < 0.001, respectively). Interestingly, no such relationship was found in TE-PH, (r = 0.16, p = ns). CONCLUSION: In contrast to arterial PH, pressure wave prematurely reflected from the intraluminal thrombi seem to disturb the RV ejection pattern and its correlation with exercise tolerance in TE-PH. Whether progression or effects of treatment on arterial PH can be assessed by monitoring changes in Doppler-derived indices of RV--pulmonary arterial coupling requires further studies.


Subject(s)
Echocardiography, Doppler , Hypertension, Pulmonary/etiology , Hypertension/complications , Pulmonary Artery/pathology , Pulmonary Embolism/complications , Ventricular Dysfunction, Right/diagnostic imaging , Adolescent , Adult , Aged , Blood Flow Velocity , Exercise Test , Female , Humans , Hypertension/pathology , Hypertension/physiopathology , Hypertension, Pulmonary/pathology , Hypertension, Pulmonary/physiopathology , Male , Middle Aged , Pulmonary Artery/diagnostic imaging , Pulmonary Embolism/pathology , Pulmonary Embolism/physiopathology , Stroke Volume , Ventricular Dysfunction, Right/etiology , Ventricular Dysfunction, Right/pathology , Ventricular Dysfunction, Right/physiopathology
5.
Pol Arch Med Wewn ; 111(4): 477-82, 2004 Apr.
Article in Polish | MEDLINE | ID: mdl-15517762

ABSTRACT

Beraprost sodium (BPS)--an orally active prostacyclin analogue--improves haemodynamic parameters and quality of life in group of patients with pulmonary arterial hypertension. Effect of long-term therapy with BPS is not well defined. This study assesses influence of long-term therapy with BPS on the survival of patients with precapillary pulmonary hypertension. Studied group consisted of 25 patients with precapillary PH (18 F, 7M, aged 34 +/- 13,9 years). Sixteen patients were diagnosed with primary PH, 3 pts had PH associated with connective tissue disease, 5 pts developed PH in course of congenital systemic to pulmonary shunt, and 1 patient suffered from inoperable chronic thromboembolic PH. At time of diagnosis 15 pts presented exercise impairment of WHO class II and 10 pts were in functional class III. All studied subjects had complete hemodynamic assessment of right heart and obtained values were used for estimation of hypothetic survival using prognostic equation proposed by D'Alonzo et al. On follow-up period patients received BPS in the highest tolerated dose (80-480 mg daily). During a follow-up period (mean: 22 months) 7 patients died. Cumulative survival rate BPS group was significantly higher in BPS group comparing to hypothetical survival at 6 months (96% (95% CI: 88-104%) vs 73% (95% CI: 67-78%), p = 0.02) and 12 months (94% (95% CI: 84-104%) vs 65% (58-71%), p = 0.01), respectively. At 18 and 24 months differences between BPS virtual and hypothetical survival were not statistically significant. There was no correlation between survival and maximal achieved dose of BPS. These results suggest, that BPS improves prognosis of patients with precapillary PH during 12 months after initiation of therapy. Later effect of BPS seems to decrease, requiring changing or intensification of therapy.


Subject(s)
Epoprostenol/analogs & derivatives , Epoprostenol/administration & dosage , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/mortality , Platelet Aggregation Inhibitors/administration & dosage , Thromboembolism/complications , Vasodilator Agents/administration & dosage , Adolescent , Adult , Aged , Drug Administration Schedule , Female , Humans , Hypertension, Pulmonary/etiology , Male , Middle Aged , Survival Analysis
6.
Kardiol Pol ; 58(1): 27-33, 2003 Jan.
Article in English | MEDLINE | ID: mdl-14502299

ABSTRACT

Atrial septostomy (AS) emerges as a potential therapeutic option in severe primary pulmonary hypertension (PH). AS isa transluminal intervention consisting of perforation of interatrial septum and balloon dilatation. During the procedure an atrial septal defect is created to a diameter permitting right-to-left shunt with the aim of correcting abnormal preload of both ventricles, leading to hemodynamic and functional consequences. We present two patients characterised by severe right ventricular failure. The second patient with rapid clinical deterioration required ,,rescue" rather than elective AS. Despite similar, small sizes of balloons (8 and 6 mm, respectively) used during both procedures, elective AS resulted in a significant and persistent hemodynamic (CI increased from 2.0 to 2.3 1/min/m(2)) and functional improvement while ,,rescue" AS despite short term improvement resulted in an uncontrolled systemic hypoxemia and did not prevent death 28 days after the procedure. Although AS is an invasive and palliative method, it offers persistent functional improvement in patients with primary PH. In view of poor prognosis and limited therapeutic options in Poland, elective AS should be considered as a potentially valuable intervention in patients with primary PH in our country.


Subject(s)
Cardiac Catheterization/methods , Heart Septal Defects, Atrial/surgery , Heart Septum/surgery , Hypertension, Pulmonary/surgery , Adult , Catheterization , Female , Heart Atria , Humans , Time Factors , Treatment Failure , Treatment Outcome , Ventricular Dysfunction, Right/surgery
7.
Circulation ; 108(7): 844-8, 2003 Aug 19.
Article in English | MEDLINE | ID: mdl-12900346

ABSTRACT

BACKGROUND: Right ventricular failure is a leading cause of death in patients with chronic pulmonary hypertension (PH). We checked whether detection of cardiac troponin T (cTnT), a specific marker of myocyte injury, could be useful in prognostic stratification of those patients. METHODS AND RESULTS: Initial evaluation of 56 clinically stable patients (age 41+/-15 years) with pulmonary arterial (51 patients) or inoperable chronic thromboembolic (5 patients) PH (mean pulmonary arterial pressure 60+/-18 mm Hg) included cTnT test, allowing detection of its serum levels > or =0.01 ng/mL [cTnT(+)]. cTnT was detectable in 8 of 56 (14%) patients (mean+/-SD, 0.034+/-0.022; range, 0.010 to 0.077 ng/mL). Despite similar pulmonary hemodynamics, they had higher heart rate (92+/-15 versus 76+/-14 bpm, P=0.004), lower mixed venous oxygen saturation (50+/-10% versus 57+/-9%, P=0.04), and higher serum N-terminal pro-B-type natriuretic peptide (4528+/-3170 versus 2054+/-2168 pg/mL, P=0.03) and walked less during the 6-minute walk test (298+/-132 versus 396+/-101 m, P=0.02). Cumulative survival estimated by Kaplan-Meier curves was significantly worse at 24 months in cTnT(+) compared with cTnT(-) (29% versus 81%, respectively, log-rank test P=0.001). Multivariate analysis revealed cTnT status (hazard ratio, 4.89; 95% CI, 1.18 to 20.29; P=0.03), 6-minute walk test (hazard ratio, 0.93 for each 10 m; P=0.01), and pulmonary vascular resistance (hazard ratio, 1.13; P=0.01) as independent markers of mortality. All 3 cTnT(+) patients who survived the follow-up period converted to cTnT(-) during treatment. CONCLUSIONS: Detectable cTnT is a so-far ignored independent marker of increased mortality risk in patients with chronic precapillary PH, supporting the role of progressive myocyte injury in the vicious circle leading to hemodynamic destabilization.


Subject(s)
Capillaries/physiopathology , Hypertension, Pulmonary/blood , Hypertension, Pulmonary/diagnosis , Lung/blood supply , Troponin T/blood , Adult , Biomarkers/blood , Chronic Disease , Disease Progression , Echocardiography , Exercise Tolerance , Female , Follow-Up Studies , Hemodynamics , Humans , Hypertension, Pulmonary/physiopathology , Male , Predictive Value of Tests , Prognosis , Proportional Hazards Models , Reproducibility of Results , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...